eli lilly and company weight loss drug - Search News

News

Eli Lilly, Weight Loss and obesity drugs

Seeking Alpha · 2d

Eli Lilly: A New Leader In Weight Loss Drugs Is Clearly Emerging

Eli Lilly gains ground with Orforglipron’s success, showing growth potential and risks from momentum and tariffs. Read why LLY stock is a buy.

Houston Chronicle on MSN · 12h

Eli Lilly targets Houston-based Empower Pharmacy over copycat diabetes, weight loss drugs

Big Pharma has put a Houston pharmacy squarely in the crosshairs of its quest to weed out copycat versions of wildly popular diabetes and weight loss drugs. Eli Lilly, the maker of the diabetes drug Mounjaro and weight loss drug Zepbound,

The New York Times · 5d

What to Know About Eli Lilly’s Daily Pill for Weight Loss

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes.

4don MSN

Eli Lilly says GLP-1 pill for diabetes and weight loss effective in study, plans to seek FDA approval

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

4hon MSN

Novo Nordisk applies for FDA approval in tightening race for weight loss pill

Novo Nordisk, maker of Ozempic, applied for FDA approval for a weight loss pill, less than a week after rival Eli Lilly's clinical trial success.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results